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Abstract 
In today’s world of ever evolving pathogens and rapidly acquired antibiotic resistance, 
the characterization of virulence factors has become increasingly important. Elucidating the 
mechanisms of action of these factors allows not only for a fundamental understanding of 
how microorganisms cause disease but also the identification of putative vaccine candidates. 
This work focuses primarily on trans-envelope molecular machinery in Gram-negative 
opportunistic pathogens, specifically, the type IV pili of nontypeable Haemophilus influenzae 
(NTHi) and the type VI secretion system of Acinetobacter baumannii. Each system mediates 
a variety of cellular processes and may be involved in the progression of disease in humans; 
therefore each is of great interest to the wellbeing of society. Here, we describe the 
characterization of components of NTHi type IV pili and A. baumannii type VI secretion in 
order to gain further insight into their biogenesis and function. 
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Dissertation Organization 
This dissertation is organized into 4 chapters. Chapter 1 is an introduction containing 
background regarding nontypeable Haemophilus influenzae, type IV pili,  
Acinetobacter baumannii and type VI secretion. Chapter 2 describes the study of two 
nontypeable H. influenzae proteins, ComB and ComC, which are required for type IV pili 
production and/or function. Chapter 3 examines two genes, tssB and tssD and their products 
in the context of their role in bacterial competition via a type VI secretion system. General 
conclusions and ideas for future research are discussed in Chapter 4.   
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Chapter 1. General Introduction 
Nontypeable Haemophilus influenzae  
Background and History 
Nontypeable Haemophilus influenzae (NTHi) is a Gram-negative bacterium that is part of 
the normal human microbiota, normally residing asymptomatically in the nasopharynx. 
Although NTHi is part of the normal microbiota, the microbe is able to cause disease under 
certain circumstances, and thus, is known as an opportunistic pathogen (36). NTHi is a 
significant causative agent of middle ear infections in children. There are currently no 
effective clinical treatments for middle ear infections caused by NTHi. The prevalence of 
middle ear infections in children and the lack of effective treatment options makes the 
development of new strategies necessary to reduce the prevalence of NTHi-induced 
infections (36).  
Clinical Disease and Significance  
NTHi can cause a variety of diseases such as pneumonia, sinusitis, exacerbations of 
chronic obstructive pulmonary disease and otitis media (OM). OM is a global health concern 
and a significant cause of morbidity in children, who are particularly vulnerable to OM due 
primarily to their immature immune systems and the anatomy of the juvenile Eustachian tube 
(36). In the United States, OM is the number one cause for pediatric visits to the emergency 
room and for prescriptions of antibiotics to children. Unfortunately, antibiotics have been 
found to be ineffective as a treatment for OM because of low drug bioavailability in the 
middle ear space and NTHi resides in the middle ear in a biofilm (2). The inherent antibiotic 
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resistance phenotype conferred by life within a biofilm, such as reduced growth rate and 
limited antibiotic penetration only adds the recalcitrance of NTHi-induced OM (2). Children 
that suffer from chronic OM that cannot be successfully treated with antibiotics often require 
tympanostomy tube insertion, in order to ventilate the middle ear cavity. This intervention is 
not a treatment, only an alleviation of symptoms associated with OM. Tympanostomy tube 
insertion requires the use of general anesthetic; consequently, OM is also the primary reason 
for the use of general anesthetic in children, which is itself a risk and can result in death (2). 
Type IV Pili 
Background and History 
Type IV pili (Tfp) are dynamic surface appendages that are evolutionarily related to  
type II secretion systems and are produced by a variety of bacterial pathogens including  
Neisseria spp., Salmonella spp., and Escherichia coli (33). A collaboration between the 
laboratories of Dr. Robert S. Munson Jr. and Dr. Lauren O. Bakaletz demonstrated that NTHi 
express functional Tfp (3).  
Type IV Pilus Mediated Phenotypes 
Type IV pili mediate a variety of phenotypes; including twitching motility, adherence to 
surfaces, and competence. Twitching motility involves the repeated extension, attachment 
and retraction of the pilus fiber in an ATP dependent process. As stated before, pili can 
mediate attachment to surfaces, both abiotic and biotic. This can be a result of pili interacting 
directly with a host cell or abiotic surface or interactions between Tfp. The end product of 
this process is increased bacterial adherence and in the case of biotic surfaces, an increased 
chance of colonizing a potential host (41). Competence is the uptake of exogenous DNA, and 
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may contribute to virulence by allowing a microbe to take in foreign DNA as a nutrient 
source or, more critically, as a source of new genes (1). 
Type IV Pilus Nomenclature 
The nomenclature of Tfp systems is a quagmire. The most well characterized Tfp belong 
to members of the genera Pseudomonas and Neisseria. These systems have completely 
different naming conventions for each subunit of the Tfp complex, which requires intimate 
familiarity with each system or tables for cross-reference. For the purposes of this thesis, 
Pseudomonas nomenclature is used in describing what is known regarding Tfp machinery 
due it’s similarly to a portion of the nomenclature for subunits that comprise NTHi Tfp. 
Type IV Pilus Machinery 
Type IV pili are dynamic macromolecular machines that span both the  
inner- and outer- membranes of Gram-negative bacteria. These machines are conserved 
across a number of bacterial genera and consist of a set of core proteins. Tfp can be 
categorized into two major groups, type IVa and type IVb, by the length and sequence of 
their major pilin subunits. Also in general, type IVa pili are generally produced by respiratory 
pathogens while type IVb pili are generally produced by enteric pathogens (10). 
The major pilin subunit, PilA comprises the bulk of the Tfp pilus body. All type IV pilins 
are similar in structure with an extended N-terminal alpha-helical tail that connects the 
globular beta-sheet region as the head. The pilus filament is comprised of many PilA 
subunits that pack together in a helical arrangement through interactions with the N-terminal 
alpha-helical region (10). 
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The pilus extends through the outer membrane through a gated channel called the 
secretin. The secretin is a homo-multimeric complex comprised of, in most Tfp systems,  
12-14 individual PilQ subunits. The stability of the secretin is affected a pilotin generally 
found in the inner-leaflet of the outer-membrane and by components of the Tfp  
inner-membrane machinery (1). 
The Tfp inner-membrane complex functions to rapidly polymerize and depolymerize Tfp 
and is much more variable in structure than the outer-membrane complex. Type IVa pilus 
inner-membrane complexes, such as the case for Pseudomonas, usually contain a  
cytoplasmic protein associated with two bitopic inner membrane proteins, and an  
inner-membrane lipoprotein. Type IVb pili inner-membrane complexes generally consist of a 
polytopic platform protein, a variable number of bitopic inner-membrane proteins, and at 
least one ATPase.  
The bitopic inner-membrane proteins of the Pseudomonas aeruginosa Tfp  
inner-membrane complex are PilN and PilO. These proteins have no known function, but are 
predicted to be involved in stabilization of the Tfp inner-membrane complex. Bitopic  
inner-membrane proteins often interact with each other and platform proteins. PilN and PilO 
were observed to form homo- and hetero-dimers. The platform protein, PilC, is hypothesized 
to function in the formation of the inner-membrane complex. PilP is the secretin  
dynamic-associated protein which interacts with the secretin and the two bitopic  
inner-membrane proteins. PilP is also believed to participate in gating of the secretin. 
ATPases are hexameric proteins that are required for functional Tfp and mediate the 
extension and retraction pili. Energy for extension and retraction is generated by the 
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hydrolysis of ATP molecules. There are three ATPases in Pseudomonas, PilB, PilT, and PilU 
(1). 
NTHi Type IV Pili 
The NTHi, strain 86-028NP genome (12) encodes two operons, pilABCD and 
comABCDEF, that are believed to encode the core set of proteins responsible for the 
biogenesis of a Type IVa pilus.  The body of the pilus is comprised of the major pilin subunit 
encoded by pilA (1). pilB encodes the putative extension ATPase, which transfers energy in 
the form of ATP to extend the pilus from the periplasm through the outer-membrane into the 
extracellular environment. pilC encodes a putative Tfp inner-membrane platform protein. 
pilD encodes the major pilin peptidase, which cleaves the leader peptide from PilA and is 
necessary for Tfp production (unpublished, Munson).  
The com operon of NTHi, strain 86-028NP has a similar arrangement to the  
pilMNOPQ operon which plays a role in type IV pilus biogenesis in P. aeruginosa (1). comA 
encodes a putative cytoplasmic protein of unknown function. The comB gene and the comC 
gene also encode proteins with no known functions. However, ComB and ComC share 
protein sequence similarity to the P. aeruginosa Tfp biogenesis proteins PilN and PilO, 
respectively. comD encodes a putative periplasmic protein that is thought to affect secretin 
multimerization. The secretin, encoded by comE, is an outer-membrane complex of multiple 
subunits of ComE that facilitates passage of the Tfp through the outer-membrane. Finally, 
comF encodes a protein of unknown function. Mutation in any one of these genes results in a 
loss of transformation, a phenotype linked to Tfp (7).  
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With regards to NTHi biology, Tfp have been shown to play a role in competence, 
twitching motility, biofilm formation, adherence to airway epithelial cells and colonization of 
a mammalian host (3, 7, 26, 27). NTHi PilA has proven to be an ideal target for the design of 
a vaccine to combat NTHi-induced OM. In a chinchilla model of NTHi-induced 
experimental OM, animals that were administered a PilA-based vaccine were protected from 
NTHi challenge. In addition, animals in which OM was induced prior to vaccine delivery 
exhibited less severe disease indicators and the infection was cleared sooner than in animals 
that received adjuvant alone.  These results indicate both a therapeutic and preventative 
nature to a PilA-derived vaccine. This vaccine candidate has been formulated to be 
administered via a non-invasive transcutaneous regimen that demonstrates efficacy as both a 
therapeutic and preventative to target NTHi-induced OM (38-40). 
Acinetobacter baumannii 
Background and History 
Acinetobacter baumannii is a Gram-negative opportunistic pathogen that has garnered 
much attention as the cause of nosocomial infections. Acinetobacter strains are known to be 
ubiquitous in the environment; however, the natural reservoir of A. baumannii is unknown. 
Recently, evidence has been presented that suggests this organism is able to persist both 
within human hosts and in health care facilities. Of greatest concern to the medical 
community, and what has most contributed to the emergence of this organism into the public 
spotlight, is A. baumannii’s rapid acquisition of multidrug resistance. Strains of A. baumannii 
that are resistant to every antibiotic currently in clinical use have been reported, making the 
discovery of novel treatment and prevention strategies imperative (44).  
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Clinical Disease and Significance 
The natural ability of A. baumannii to survive harsh conditions such as prolonged periods 
of desiccation on inanimate surfaces, which are common in hospital elements such as 
furniture, medical equipment, as well as plastic and glass surfaces, contribute to the 
emergence of this organism as an important causative agent of nosocomial infections  
(24, 54). A. baumannii generally infects those with weak immune systems making children, 
the elderly, the wounded, and the immune-compromised particularly vulnerable. Most of the 
severe human infections caused by A. baumannii are thus acquired in health care facilities.  
A. baumannii is responsible for up to 10% of intensive care unit infections (15, 43, 51), up to 
7% of pneumonias, and also causes infections of intravascular devices, ulcers, surgical sites 
and the urinary tract in patients (5, 25, 54). A. baumannii infections are associated with 
disturbingly high mortality rates, which range from 20% to more than 50% (18). 
Compounding the threat of A. baumannii is its ability to acquire and exhibit antibiotic 
resistance, which is thought to significantly contribute to the virulence of this pathogen  
(11, 13). The existence of pan-resistant strains of A. baumannii has been reported, which 
indicates we are approaching the end of the antibiotic era for this bacterium (19). 
Type VI Secretion System 
Background and History 
Type VI secretion systems (T6SS) are trans-membrane molecular apparatuses that were 
first discovered in 2003 in Rhizobium leguminosarum (46). These systems are involved in the 
exportation of effector proteins and have been likened to needles or syringes, capable of 
injecting effectors directly into foreign cells. The ability of T6SS to secrete molecules in this 
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fashion is thought to derive from their structural relation to phage injection machinery. These 
similarities have caused T6SS to be depicted as inverted bacteriophage-like machines. Genes 
that encode T6SS are present in approximately 25% of all sequenced Gram-negative bacteria 
and are often associated with virulence and host infection by pathogens (49). 
Type VI Secretion Related Phenotypes 
Bacterial and eukaryotic cell targeting are the most fully characterized processes carried 
out by T6SS. Bacterial cell targeting allows T6SS producing organisms to compete with 
other bacteria, often by killing or inhibiting the growth of the foreign species  
(23, 32, 35, 45, 47). This allows organisms to be more successful at adapting to and surviving 
in their environments, which implies that T6SS could be relevant to the outcome of 
polymicrobial human diseases. The ability of T6SS to target eukaryotic cells may also affect 
a bacterial species capacity to be a pathogen. Numerous studies have shown that T6SS 
mutants are less virulent than wild-type strains in animal models of disease. The molecular 
basis for this phenotype is not well characterized (46); however, a series of experiments on 
the Vibrio cholerae virulence associated secretion system demonstrated that T6SS could 
affect macrophage cell rounding and intestinal inflammation in mice (46, 49).   
Type VI Secretion Machinery 
Type VI secretion systems traverse both the inner- and outer-membranes of  
Gram-negative bacteria. The genes that encode the components of T6SS are generally 
grouped in tightly clustered operons. An organism may carry more than one T6SS gene 
cluster. These clusters are usually divergent and likely the result of horizontal gene transfer. 
Thirteen conserved subunits compose the core T6SS apparatus. Aside from the 13 core 
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subunits, genes found within T6SS gene clusters may encode additional accessory proteins 
(6, 9).  
The genes that encode the core components of T6SS can be organized into three 
categories, genes that encode inner-membrane proteins, bacteriophage related proteins, and 
proteins with no predicted function. The best understood T6SS belong to Edwardsiella tarda 
and Vibrio cholerae. The first group includes genes that code for TssL, TssM and TssJ. The 
second group includes the genes that code for Hcp, VgrG, TssB, TssC, and TssE, and the 
third group includes TssA, TssF, TssG, TssK (49). 
TssL and TssM are localized to the inner-membrane and are homologous to IcmH and 
IcmF, which are components of the Legionella pneumophilia T6SS. Interestingly, IcmH and 
IcmF lack orthologs in other type IV secretion translocons (52). IcmH and IcmF interact with 
each other, therefore TssL and TssM are thought to interact with each other as well. The bulk 
of TssL is localized in the cytoplasm whereas TssM is localized in the periplasm. The 
cytoplasmic domain of TssM contains an ATP binding and hydrolysis motif. The function of 
this motif depends on the bacteria in which the system is present. TssJ a lipoprotein that is 
localized to the outer-membrane and interacts with TssM (49). 
The two most-extensively characterized components of any T6SS are TssD (Hcp) and 
TssI (VgrG), which belong to the bacteriophage-related group of proteins. These proteins 
share secondary structure with phage injection constituents. TssD structurally resembles gpV, 
the major tail protein of phage λ. TssI assumes a structure similar to the gp27/gp5 complex, 
the tail spike of bacteriophage T4 used for membrane penetration. TssC assembles into a 
tubular structure that is similar to the T4 contractile sheath. This structure is large enough to 
enclose a tube composed of TssD subunits, and is therefore predicted to propel TssD out of 
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the cell upon contraction. TssE shares primary sequence homology to the T4 bacteriophage 
baseplate protein gp25 (49). 
Acinetobacter baumannii Type VI Secretion System 
In A. baumannii strain M2 a putative T6SS gene cluster,  
asaA-tssBCDEFG-asaB-tssM-tagFN-asaC-tssHAKL-asaDE, which extends over a 22 kb 
region, was identified. A nomenclature for the A. baumannii T6SS has been proposed (21) 
but differs significantly from the agreed upon standardized nomenclature for T6SS (48). The 
standard T6SS nomenclature will be followed in this dissertation. The genome of  
A. baumannii strain M2 was sequenced (data not shown) and the resultant contig set was 
screened for genes and/or predicted proteins that showed sequence identity to genes or 
proteins associated with other T6SS. This targeted search resulted in the identification of a 
gene cluster of 18 open reading frames and 3 additional genes that are predicted to encode  
12 of the 13 core T6SS proteins (Tss), 2 proteins associated with T6SS in other bacteria 
(Tag) and 5 proteins that appear to be encoded only in Acinetobacter spp. (Asa). Three of 
these genes are predicted to encode orthologs of tssI. The predicted functions of many of the 
genes within the strain M2 T6SS gene cluster are unknown but are conserved amongst T6SS 
(21). However, there are functional predictions for the products of several genes within this 
gene cluster. In other bacteria, a homolog of the T4 phage baseplate must assemble in the 
inner- and outer-membrane prior to T6SS assembly (49). The product of the tssD gene shares 
sequence identity with a homolog of a protein found in the T4 bacteriophage baseplate. The 
tssB gene encodes a protein that share sequence identity with a subunit of the outer 
contractile sheath of T6SS characterized in other bacteria. The TssB homologue is required 
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for the physical extension of the inner core through the inner and outer membranes and 
subsequent secretion of effectors. The tssD gene encodes a protein, which has homology to 
gpV, the major tail protein of phage λ. 
Summary with Goals and Hypothesis 
The overall goal of this study was to further characterize the trans-membrane molecular 
machinery of NTHi and A. baumannii, specifically the Tfp of NTHi and the T6SS of  
A. baumannii. We hypothesized that the NTHi Tfp proteins ComB and ComC are oriented 
and interact similarly to PilN and PilO of Pseudomonas. We also hypothesized that  
A. baumannii produces a functional T6SS that mediates contact dependent bacterial 
competition.  
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Chapter 2. The NTHi Type IV Pilus-Associated Proteins, ComB 
and ComC are Bitopic Inner-Membrane Proteins that Interact 
Introduction 
Nontypeable Haemophilus influenzae (NTHi) is one of the three primary opportunistic 
bacterial pathogens that are responsible for middle ear infections, or otitis media, in children. 
We have demonstrated that NTHi produce surface bound appendages called type IV pili and 
that NTHi Tfp play a role in competence, adherence to epithelial cells, biofilm formation, 
and colonization of the mammalian nasopharynx (7, 27). The core set of proteins that are 
believed to compose the Tfp apparatus in NTHi, strain 86-028NP are encoded by two 
operons, pilABCD and comABCDEF. These genes were identified by sequence similarity, 
presence of conserved domains (3) and analysis of the competence regulon (42, 53). 
Mutational analysis was also used to identify these genes (8). These analyses revealed that 
NTHi Tfp belong to the type IVa group of Tfp, based on the sequence and length of pilA. 
Although several of the genes responsible for Tfp biogenesis have been identified, little is 
known about the proteins encoded by these genes. We proposed to further investigate 
components of NTHi Tfp. Herein, we describe the experiments designed to elucidate the 
topology and interactions of the NTHi Tfp proteins ComB and ComC.  
Materials and methods 
Strains and culture conditions  
NTHi, strain 86-028NP was grown either at 37˚C, 5% CO2 on chocolate agar or at 37˚C 
in brain heart infusion broth (BHI) (Difco, Detroit, MI) to which 2 µg heme  
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(Sigma, St. Louis, MO) and 2 µg of ß-NAD (Sigma) were added per ml of medium (sBHI). 
Escherichia coli were grown on Luria agar (L-agar) or in Luria broth (L-broth) (Difco). In 
the case of alkaline phosphatase assays, E. coli was grown in RM medium, a minimal media 
which lacks a carbon source. RM media was supplemented with glucose or glycerol (17). 
Media were supplemented with spectinomycin (Sigma) at a concentration of 200 µg/ml, 
ampicillin (Sigma) at a concentration of 50 µg/ml and/or kanamycin (Sigma) at a 
concentration of 20 µg/ml as needed. IPTG (Sigma), a structural mimic of allolactose, was 
added at a final concentration of 0.5 nM to E. coli cultures to induce the T7 expression 
system when needed. Arabinose (Sigma) was added to E. coli cultures a final concentration 
of 0.2% to induce gene expression when required. 
Bacterial Strain and Plasmid Construction 
All strains and plasmids used in this study are listed in Table 1.1. In order to determine 
the orientation of ComC in the inner-membrane, translational fusions to the genes encoding 
green fluorescent protein (GFP) or alkaline phosphatase (PhoA) were made at specific amino 
acid residues such that each protein contained a fusion in the predicted cytosolic portion, 
periplasmic portion or at the C-terminal end of ComC. A set of 6 plasmids was constructed 
for expression of translation fusions to ComC, three constructs with translational fusions to 
GFP and three constructs with translational fusions to PhoA. Forward and reverse primers, 
both containing NheI restriction sites, were used to amplify region of comC from the 
beginning of comC to codons encoding specific amino acid residues on the 3’ end. For ComC 
fusions, amplified regions contained the ATG start site and sequence encoding up to the 
48 and 173
 
amino acid residues. The PCR products encoding each fragment were digested 
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with NheI and ligated with pBAD-GFP cut with NheI. Translational fusions between ComC 
with PhoA were constructed in the same manner as the gfp fusions but KpnI was used to 
restrict PCR products and these products were ligated into pBAD-PhoA precut with KpnI. 
Fusions encoding the first 15 amino acids of ComC to GFP or PhoA were constructed by 
PCR amplification of pBAD-GFP or pBAD-PhoA primers that contained sequence encoding 
the first 15 aa of ComC. These products were self-ligated. All ligation products were 
transformed into E. coli LMG194 and transformants plated on RM media with selection.  
E. coli clones harboring plasmids with fusions in the correct orientation were verified by 
sequencing. 
Alkaline Phosphatase Activity 
E. coli clones that contained pBAD constructs encoding truncations of ComC fused to 
PhoA were cultured in RM media supplemented with 0.2% glucose and grown to mid-log 
phase. Cultures were grown in the presence of glucose to inhibit expression of fusion 
proteins under the control of the araBAD promoter via catabolite repression. The cultures 
were then washed with RM media supplemented with 0.2% glycerol. Glycerol is a  
carbon-source that will not inhibit expression of genes under the control of the araBAD 
promoter. Expression of the translational fusions was induced by the addition of arabinose to 
a final concentration of 0.2%. Cells were harvested by centrifugation and subjected to an 
alkaline phosphatase activity assay as described by Duffy et al. (8).  
Protein Expression and Purification 
E. coli BL21 (DE3) (Invitrogen) cells carrying plasmids for expression of the  
6xHIS-tagged periplasmic domains of ComB and ComC were cultured in L-Broth at 37˚C 
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with shaking. Cells were grown to an A600 of 0.6, at which time protein expression was 
induced. Expression was induced by the addition of Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at a final concentration of 0.5 mM. The expression of the periplasmic domains of 
ComB and ComC was carried out at 19˚C with shaking for 4.5 h to encourage proper protein 
folding. Upon completion of induction, cultures were washed twice in PBS. 
Dithiobis[succinimydlpropionate] (DSP, Thermo Scientific), a nonpolar membrane 
permeable crosslinking agent, was dissolved in dimethylsulfoxide (DMSO) and added to 
cells resuspended in PBS to a final concentration of 2 mM. Cross-linking was carried out for 
30 min at room temperature, then Tris, pH 7.5 was added to a final concentration of 20 mM 
to quench cross-linking. Cells were washed twice in PBS, resuspended in column loading 
buffer (Novagen) and lysed via bead disruption using B lysing matrix tubes  
(MP Biomedical). Cell lysate was centrifuged at 100,000xg to separate the soluble and 
insoluble fractions. Immobilized metal affinity chromatography (IMAC) was used to purify 
6xHIS-tagged proteins from soluble cell lysate. Ni-NTA His-Bind resin (Novagen) was used 
following manufactures protocol for purification under denaturing conditions. 
Protein Analysis and Identification 
Concentration of protein in samples was determined and standardized using the 
bicinchoninic acid assay (Pierce, Rockford, IL) (35). Sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) was used to separate protein samples by size. Samples were 
mixed with an equal volume of 2x Laemmli sample buffer with added 2-mercaptoethanol 
(BioRad, Hercules, CA), boiled for 10 min, cooled to room temperature and then resolved on 
4-20% Mini-Protean TGX Precast gels (Bio-Rad). Resolved proteins were transferred from 
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SDS-PAGE gels to nitrocellulose for western blotting. Gels were blocked for 1 h with 2% 
bovine serum albumin. Rabbit polyclonal antibodies directed against ComB, residues 26-42, 
and ComC, residues 19-40, (Genscript, Piscataway, NJ) at a dilution of 1/4000 were used as 
primary antibodies in western blot analysis. The secondary antibody, an alkaline phosphate 
conjugated goat -rabbit antibody (Invitrogen), was added at a dilution of 1:2500. 
Colorimetric detection with 5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt and  
nitro-blue tetrazolium chloride (BCIP/NBT)(Sigma) was used to verify the presence of 
protein.  
Results and Discussion 
ComB and ComC are Bitopic Inner-membrane Proteins 
Experimental evidence has shown that PilN and PilO of Pseudomonas aeruginosa, 
homologs of ComB and ComC respectively, are bitopic inner-membrane proteins that 
comprise part of the Tfp machinery. Furthermore, Phyre2 structure prediction provided 
evidence that ComB and ComC may have similar structures to the PilN and PilO proteins 
from Pseudomonas. Thus, we hypothesized that ComB and ComC are also bitopic  
inner-membrane proteins with a similar topographical orientation as PilN and PilO. 
TMHMM was used to predict the topology of ComC based on secondary structure prediction 
(29). Translational fusions between green fluorescent protein (gfp) or alkaline phosphatase 
(phoA) at distinct residues in each protein, based on TMHMM topology predictions, see 
Figure 1, were utilized to determine topology. Translational fusions with gfp will emit green 
fluorescence when excited and when the GFP domain is located in the cytoplasm but not 
when the GFP domain is in the periplasm due to improper folding of GFP in this 
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compartment. Conversely, translation fusions with phoA will exhibit alkaline phosphatase 
activity when the PhoA domain is localized to the periplasm but not when the phoA domain 
is localized to the cytoplasm due to the lack of disulfide bond formation necessary for proper 
PhoA activity. This experiment demonstrated that ComC contains a larger periplasmic 
domain, a transmembrane domain, and a smaller cytoplasmic domain, results shown in 
Figure 2A and 2B. These results are consistent with the model presented in Figure 1B. The 
topology mapping experiments concerning ComB, performed by Anna Bailey, yielded 
similar results (Data not shown). 
Periplasmic Domains of ComB and ComC Interact 
To study interactions between ComB and ComC, the soluble periplasmic domains of 
ComB and ComC were expressed in E. coli. The periplasmic domain of ComC with a  
C-terminal His tag fusion was co-expressed with the periplasmic domain of ComB. After  
co-expression, proteins were cross-linked with DSP and cells were lysed via bead beating 
and then subjected to centrifugation. IMAC was performed to purify 6xHIS tagged proteins 
from soluble cell lysate fractions. ComB∆2-35 and ComC∆2-42-HIS, when co-expressed,  
co-eluted at an imidazole concentration of 150 mM as evidenced by Western blots using 
antibodies specific to ComB or ComC. Western blots are shown in Figure 3. The  
co-expression of ComB∆2-35-HIS and ComC∆2-42 did not yield interpretable results due to 
nonspecific binding of ComC∆2-42 to the nickel columns. Samples were also visualized by 
Coomassie staining. Stained gels exhibited bands corresponding to the approximate 
molecular mass of hetero-dimers of ComB∆2-35 and ComC∆2-42-HIS as well as hetero-dimers 
of ComB∆2-35-HIS and ComC∆2-42. Putative hetero-dimer bands were excised and submitted 
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for mass spectroscopy analysis. Peptides, which were identified by mass spectroscopy, are 
indicated in red in Figure 4. These peptides correspond to the periplasmic domains of ComB 
and ComC. These data indicate an interaction between the NTHi Tfp proteins ComB and 
ComC and further support the hypothesis that they have similar functions as PilN and PilO of 
Pseudomonas. 
Concluding Remarks 
The data generated from these experiments demonstrated that ComB and ComC are both 
bitopic inner-membrane proteins and can interact as heterodimers via their periplasmic 
domains. These data fill gaps in our understanding of NTHi Tfp structure and biogenesis. 
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Chapter 3. The A. baumannii Type VI Secretion-Associated 
Genes, tssB and tssD, Play a Role in Inter-Bacterial Competition 
Introduction 
Acinetobacter baumannii is a Gram-negative, nosocomial pathogen that causes 
pneumonia, surgical site infections, bacteremia, and necrotizing fasciitis, among other 
diseases in humans. In addition to the list of diseases caused by A. baumannii, many strains 
are highly antibiotic resistant. These two facts coupled together make the study of virulence 
factors in A. baumannii absolutely crucial, as the information gained may someday go 
towards new treatment development. 
A clinical isolate of A. baumannii, designated strain M2 (37), carries a gene cluster 
predicted to encode a type VI secretion system (unpublished, Carruthers). T6SS are bacterial 
secretory apparatuses that are analogous to bacteriophage injection machinery (49). Secretion 
systems such as T6SS allow bacteria to transport macromolecules and effector proteins into 
their environment or directly into other cells (4). As the products of these genes are poorly 
understood and no function has been ascribed to a T6SS produced by A. baumannii, we 
endeavored to investigate their function. This chapter describes the experiments designed to 
elucidate the role of tssB and tssD in A. baumannii strain M2 and determine the role of the  
A. baumannii T6SS. 
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Materials and methods 
Strains and culture conditions  
All strains and plasmids are listed in Table 2.1. A. baumannii strain M2, a clinical isolate 
from Cleveland Metro-Health Systems obtained from Phil Rather at Emory University, was 
used in this study (37). All bacterial strains were grown on L-agar or L-broth prior to 
experimentation. A. baumannii cultures, where appropriate, were supplemented with 
kanamycin20 µg/ml; chloramphenicol 12.5 µg/ml; spectinomycin 200 µg/ml or ampicillin 
750 µg/ml. Escherichia coli cultures were supplemented with kanamycin 20 µg/ml or 
ampicillin 50 µg/ml, where appropriate.  
Bacterial Strain Construction 
A. baumannii strain M2 clones with unmarked mutations in tssB and tssD were 
constructed using a recombineering strategy as described by Tracy et al (50). The kanamycin 
resistance cassette from Tn903 and sacB, flanked by FRT sites, were amplified from 
pRSM3542, a plasmid constructed by the Munson lab group. In the case of constructing the 
tssB mutant the resultant PCR product contained 47 bp upstream of tssB, the ATG start 
codon, an FRT site, the sacB-kan cassette, a second FRT site, the last 21 bp of  tssB including 
the stop codon and 29 bp down-stream of tssB. A similar PCR product was made in the case 
of tssD. Plasmids that carried tssB and tssD and approximately 1 kb of flanking sequence 
were constructed by ligating PCR products generated from PCR with M2 genomic DNA to 
pGEM-T-Easy (Promega). These ligated products were transformed via electroporation into 
E. coli DH5a and kanamycin resistant colonies were selected. These plasmids were purified 
from E. coli DH5a, mixed with the amplicons containing sacB-kan flanked by 50 bp of 
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homology, and electroporated into E. coli DY380 cells that had been heat shocked at 42˚C 
for 15 min in order to carry out homologous recombination. Plasmids were purified from 
kanamycin resistant clones and verified by sequencing. Plasmid from single clones were 
saved as pGEM-∆tssB::sacB-kan and pGEM-∆tssD::sacB-kan. Amplicons containing  
sacB-kan and 1 kb of flanking DNA 5’ and 3’ of the cassette were generated from  
pGEM-∆tssB::sacB-kan and pGEM-∆tssD::sacB-kan. One microgram of these amplicons 
was mixed with 500 µl of M2 cultures grown for 2 h from a 1:10 dilution of an overnight 
culture for natural transformation. These mixtures were plated on L-agar and incubated at 
37˚C for 4 h. Cells were then scraped from the plate and re-suspended in 500 µl of L-broth. 
Serial dilutions were performed and dilutions were plated on L-agar containing kanamycin to 
select for Acinetobacter mutants. Mutants were verified by PCR and sequencing. To obtain 
unmarked M2 mutations, E. coli DH5a harboring pFLP2, E. coli HB101 harboring pRK2013 
and mutant M2 strains were used as the donor, helper and recipient strains respectively in a 
tri-parental conjugation. Unmarked mutants were selected for on L-agar containing 
chloramphenicol and 10% sucrose at room temperature. Sucrose resistant clones were 
analyzed by PCR to verify loss of the sacB::kan cassette. Correct clones were sequenced and 
saved as M2∆tssB and M2∆tssD. 
TssD Secretion Assay 
A. baumannii strain M2 was inoculated into 20 mL of L-broth at an A600 of 0.10 and 
grown at 37˚C with shaking until an A600 of 2.50 reading was reached. Cultures were 
centrifuged at 4,000 x g, 4˚C for 20 min to remove cells. The supernatant was centrifuged at 
100,000 x g, 4˚C for 2 h to remove any insoluble material. Twenty milliliters of cleared 
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supernatants were concentrated by filtration through Ultracel 10K centrifuge filters (Amicon) 
according to the manufacturer’s protocol. SDS-PAGE and Coomassie staining were utilized 
to analyze the concentrated culture supernatants. Bands that correlated to the approximate 
size of TssD were excised and sent to The Ohio State University Mass Spectrometry and 
Proteomics Facility for identification.  
Bacterial Competition 
A. baumannii strains were inoculated into 25 mL of L-broth at an A600 of 0.10 and grown 
at 37˚C with shaking. Once an A600 of 0.60 was reached cultures were diluted to an A600 of 
0.40. For competition, A. baumannii strains were mixed at a 10:1 ratio to E. coli DH10B,  
40 µL to 4 µL, and 20 µL of these mixtures were spotted onto L-agar. Competition was 
allowed to proceed for 4 h at 37˚C. After competition, spots were excised, submerged in  
500 µL of PBS, vortexed for 3 s and serial diluted. Dilutions out to 10
-6 
were plated on  
L-agar containing streptomycin to select for E. coli. 
T6SS Contact Dependence 
The contact dependence assay was carried out in the same manner as the bacterial 
competition assay except 0.22 µm pore polycarbonate filters were placed between strains 
and/or media and dilutions out to 10
-7
 were plated.  
Results and Discussion 
Acinetobacter baumannii strain M2 Secreted TssD 
Functional T6SS are known to produce and secrete homologs of gpV. To determine if  
A. baumannii produces a functional T6SS, the secretion of the gpV homolog in  
A. baumannii, TssD, was assayed for. Acinetobacter strains were grown to late log phase in 
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L-broth. The cells were then removed from the supernatant, which was subsequently 
concentrated. Concentrated supernatants were subjected to SDS-PAGE and stained using 
Coomassie Blue as seen in Figure 5. The data show that a secreted product in the range of 
25-37 kDa was not present in the supernatant of either of the Acinetobacter tss mutant 
cultures. The protein band visible between the 25 and 37 kDa markers was submitted the 
Ohio State Mass Spectrometry and Proteomics Corps and identified as TssD. The presence of 
TssD in culture supernatants indicated that the A. baumannii strain M2 T6SS was functional 
and active during growth in culture. 
Acinetobacter baumannii Utilized a T6SS for Inter-bacterial Competition 
Bacterial T6SS are often associated with competition; they mediate the killing of other 
bacteria and can thus provide a growth advantage over would be competitors. Because the 
results of the secretion assay indicated that A. baumannii produced a functional T6SS the 
next logical step was to test whether that T6SS could facilitate the killing of other bacterial 
cells. In order to test this hypothesis, a bacterial competition assay between  
A. baumannii strain M2 and E. coli DH10B was conducted. A. baumannii strain M2 and  
E. coli DH10B were mixed at a 10:1 ratio, spotted onto L-agar, and after 4 hours of 
incubation spots were excised, homogenized in L-broth, diluted, and plated on agar selective 
for E. coli. The results shown in Figure 6 demonstrated that strain M2 was able to  
out-compete E. coli cells as compared to the no Acinetobacter control. The ΔtssB and ΔtssD 
mutants showed a lack of phenotype, which indicated that killing was T6SS mediated. 
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Acinetobacter baumannii T6SS Mediated Competition was Contact Dependent 
To establish whether the competition phenotype was contact dependent, a competition 
experiment with 0.22 µm pore filters was performed. When mixed together and spotted 
above and below a filter, as seen in Figure 7. A. baumannii strain M2 out-competed  
E. coli DH10B. It is also evident from this experiment that the location of E. coli, either 
above or below the filter, does not impact the amount of recoverable E. coli. No killing of 
 E. coli was observed when a filter separated the two species. These data supported that  
A. baumannii competes with other bacterial strains in a contact dependent manner. 
Concluding Remarks 
The results of the experiments outlined in this chapter indicated that  
A. baumannii strain M2 produced a functional T6SS, as evidenced by the tssD secretion 
assay, that A. baumannii used this system to compete with E. coli DH10B, and that 
competition was contact dependent. In addition, our data is the first to ascribe a function to 
the T6SS produced by A. baumannii, namely A. baumannii uses its T6SS to compete with 
other bacterial species in a contact dependent manner. 
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Chapter 4. General Conclusions and Future Directions 
NTHi and A. baumannii cause a number of human diseases and are difficult to manage 
with conventional antibiotic therapies. Due to the severity of the diseases associated with 
these pathogens, new treatment options must be explored. Here, we examined components of 
NTHi Tfp and A. baumannii T6SS. The inner-membrane proteins, ComB and ComC, of 
NTHi were topology mapped and shown to interact. A. baumannii was shown to produce a 
functional T6SS capable of facilitating bacterial competition in a contact dependent manner. 
Future experiments that may further characterize these virulence factors include studying the 
structures and interaction sites of ComB and ComC via x-ray crystallography and assessing 
the role of A. baumannii T6SS in a mouse model. The data discussed in this study lay the 
foundation for future research that may someday be incorporated into the development of 
new treatment strategies for infections caused by the Gram-negative opportunistic pathogens 
NTHi and A. baumannii.  
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Appendix A. Tables 
Table 1.1 Plasmids and Bacterial Strains  
Plasmid or strain Relevant characteristic(s) Reference/
Source 
Plasmids   
pGEM-TEasy General purpose cloning vector Promega 
pSmartLCKan Low copy cloning vector Lucigen 
pCOLA-Duet E. coli expression vector Novagen 
pET-Duet E. coli expression vector Novagen 
pBAD-PhoA An arabinose inducible expression vector that allows for 
C-terminal fusion to PhoA 
(34) 
pBAD-GFP An arabinose inducible expression vector that allows for 
C-terminal fusion to GFP 
(31) 
pComB-PhoA pBAD with sequence encoding ComB with a C-terminal 
fusion to PhoA 
This study 
pComC∆15-178-PhoA pBAD with sequence encoding ComC∆15-178 with a C-
terminal fusion to PhoA 
This study 
pComC∆48-178-PhoA pBAD with sequence encoding ComC∆48-178 with a C-
terminal fusion to PhoA 
This study 
pComC-PhoA pBAD with sequence encoding ComC with a C-terminal 
fusion to PhoA 
This study 
pComC∆15-178-GFP pBAD with sequence encoding ComB∆51-168 with a C-
terminal fusion to GFP 
This study 
pComC∆48-178-GFP pBAD with sequence encoding ComB with a C-terminal 
fusion to GFP 
This study 
pComC-PhoA pBAD with sequence encoding ComC with a C-terminal 
fusion to PhoA 
This study 
pComC∆15-178-GFP pBAD with sequence encoding ComB∆51-168 with a C-
terminal fusion to GFP 
This study 
pComC∆48-178-GFP pBAD with sequence encoding ComB with a C-terminal 
fusion to GFP 
This study 
pComC-GFP pBAD with sequence encoding ComC∆15-178 with a C-
terminal fusion to GFP 
This study 
pComC∆2-42 pCOLA-Duet with sequence encoding ComC∆2-42 This study 
pComC∆2-42-HIS pCOLA-Duet with sequence encoding ComC∆2-42-HIS This study 
pET-ComB∆2-35 pET-Duet with sequence encoding ComB∆2-35 This study 
pET-ComB∆2-35-HIS pET-Duet with sequence encoding ComB∆2-35-HIS This study 
pComC∆2-42 pCOLA-Duet with sequence encoding ComC∆2-42 This study 
pComC∆2-42-HIS pCOLA-Duet with sequence encoding ComC∆2-42-HIS This study 
pET-ComB∆2-35 pET-Duet with sequence encoding ComB∆2-35 This study 
pET-ComB∆2-35-HIS pET-Duet with sequence encoding ComB∆2-35-HIS This study 
Strains   
Nontypeable H. influenzae 
strain 86-028NP 
Clinical isolate from a child with OM (28) 
E. coli BL21 Star DE3 Strain for overexpression of com proteins in E. coli Invitrogen 
E. coli DH5 Cloning strain Invitrogen 
E. coli LMG194 phoA
−
 strain used for alkaline phosphatase activity 
assays 
(20) 
E. coli TOP10 Cloning strain  Invitrogen 
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Table 2.1 Plasmids and Bacterial Strains  
Plasmid or strain Relevant characteristic(s) Reference/Source 
Plasmids   
pFLP2  (22) 
pRSM574 pBR322 with Tn903 kanamycin resistance 
cassette  
This Study 
pRSM2724 pRSM574 with sacB from pFLP2, cloned via 
EcoRI  
This Study 
pKD13  (12) 
pGEM-T-Ez General cloning plasmid Promega 
pGEM-tssB pGEM, tssB region from strain M2 This study 
pGEM-∆tssB::sacB-kan pGEM-tssB, deletion/insertion of sacB::kan 
cassette 
This study 
pGEM-tssD pGEM, tssD region from strain M2 This study 
pGEM-∆tssD::sacB-kan pGEM-tssD, deletion/insertion of sacB::kan 
cassette 
This study 
pSMART LC-Kan General cloning plasmid Lucigen 
pRSM3542 pKD13, sacB::kan This study 
Strains   
Acinetobacter baumannii 
strain M2 
Metro Health Systems Clinical Isolate (37) 
 ∆tssB Acinetobacter baumannii strain M2 mutant 
containing a unmarked deletion of tssB 
This study 
 ∆tssD Acinetobacter baumannii strain M2 mutant 
containing a unmarked deletion of tssD 
This study 
∆tssB::-sacB-kan   
∆tssD::-sacB-kan  This study 
Escherichia coli DH10B General cloning strain, competitor Invitrogen 
Pseudomonas aeruginosa 
PA01 
CmS (55) 
E. coli DH5a General cloning strain Invitrogen 
E. coli EC100D General cloning strain, pir
+
 Epicentre 
E. coli DY380 Recombineering strain (30) 
E. coli HB101(pRK2013)  (14) 
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Appendix B. Figures 
Figure 1. Predicted Topology Maps of ComC in the Inner-Membrane 
 
A. Candidate topology map of ComC. This map show ComC with small periplasmic domain, 
a trans-membrane domain and a large periplasmic domain B. Candidate topology map of 
ComC. This map shows ComC with large periplasmic domain, a trans-membrane domain 
and a small periplasmic domain. The predicted activities of fusions between ComC and either 
Gfp or PhoA at specific amino acids are indicated in each panels corresponding table.  
Residues at which PhoA or GFP were fused to ComC are shown in black.  
 30 
 
Figure 2. ComC is a Bitopic Inner-Membrane Protein 
 
A. Cultures of E. coli expressing fusions of GFP to ComC at specific amino acids were tested 
to determine ComC localization and orientation in the inner-membrane. Escherichia coli that 
expressed the first 15 aa of ComC with GFP fused to the C-terminus (ComC∆16-173-GFP) 
were fluorescent, while E. coli that expressed full-length ComC with GFP fused to the  
C-terminus were not fluorescent. As GFP is active only in the cytoplasm these data indicated 
residues 1-15 of ComC are located in the cytoplasm while the C-terminal residue is not.  
B. Cultures of E. coli expressing fusions of PhoA to ComC at specific amino acids were 
tested to determine ComC localization and orientation in the inner-membrane. As PhoA is 
only active in the periplasm, these results indicated that ComC residues 48 and 173 are 
located in the periplasm, while residue 15 is not. These data suggest that ComC is a bitopic  
inner-membrane protein.  
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Figure 3. The Periplasmic Domains of ComB and ComC Interacted  
 
 
 
When the culture reached and OD600 of ~0.6, expression of the periplasmic portions of ComB 
and ComC was induced via the addition of IPTG and cultures were grown for an additional 
4.5 h at 19˚C. Protein was cross-linked with DSP, cell were lysed via mechanical disruption 
and the cell lysate was centrifuged at 100,000 x g for 1 h. Soluble protein was purified by 
IMAC under native conditions and SDS-PAGE of purified fractions followed by Western 
blot analysis was performed. Western blot analysis indicated that ComC-HIS was purified by 
IMAC and that ComB was detected in pull-downs when purifying ComC-HIS. These data 
indicated an interaction between the periplasmic domains of ComB and ComC. 
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Figure 4. Analysis of Com Complexes by Mass Spectrometry  
 
Escherichia coli BL21 (DE3) cells containing plasmids encoding the proteins described 
above were grown to early-log phase in LB and IPTG was added to induce expression of the 
periplasmic domains of ComB and ComC. Cultures were incubated overnight at 19°C. 
Protein was cross-linked with DSP and the cells were resuspended in denaturing buffer 
(SDS). Cells were lysed via mechanical disruption, lysate spun at 100,000 x g to separate 
soluble and insoluble proteins. Soluble proteins were subjected to IMAC under denaturing 
(SDS) conditions. Samples were resolved by SDS-PAGE was performed and gels were 
stained with Coomassie blue. The bands between 25 and 37 kDa that corresponded to 
potential heterodimers, as indicated by dashed boxes, were excised and submitted to The 
Ohio State Mass Spectrometry Facility for analysis. Amino acid sequences are displayed 
with identified peptides highlighted in red. 
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Figure 5. TssD is Secreted in Strain M2 and Not in the tssB and tssD Mutants 
 
Culture supernatants of A. baumannii strains grown till early stationary phase at 37˚C,  
180 rpm were cleared by centrifugation and ultra-centrifugation. Cleared supernatants were 
then concentrated 20-fold using a protein concentrator with a 10 kDa cut-off. A band with the 
approximate molecular mass of TssD was observed in the sample derived from strain M2 and 
was absent in the samples from the tssB and tssD mutants. Mass spectrometry confirmed that 
the most abundant protein the observed band from the M2 sample was TssD. 
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Figure 6. Escherichia coli was Out-Competed by A. baumannii in a T6SS-Dependent 
Manner 
 
Escherichia coli DH10B and A. baumannii strains indicated were competed against one 
another at a ratio of 1:10 respectively for 4 h. Competition mixtures were plated on L-agar 
supplemented with streptomycin at 25 ug/mL to select for the surviving E. coli population.  
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Figure 7. Competition of A. baumannii Against E. coli was Contact Dependent 
  
Escherichia coli DH10B cells plated after a 4 h competition with A. baumannii strain M2. 
The dashed line between strains and/or media signifies the presence of a 0.22 µm pore filter 
between the two bacterial populations or between bacteria and media.   
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